Jundishapur Journal of Microbiology

Published by: Kowsar

Survival Rates of Human Immunodeficiency Virus and Tuberculosis Co-Infected Patients

Ghodratollah Roshanaei 1 , Masoud Sabouri Ghannad 2 , * , Mohammad Saatchi 3 , Salman Khazaei 3 and Mohammad Mirzaei 4
Authors Information
1 Modeling of Noncommunicable Diseases Research Center, Department of Biostatistics and Epidemiology, School of Public Health, Hamadan University of Medical Sciences, Hamadan, IR Iran
2 Department of Microbiology, Research Center for Molecular Medicine, Faculty of Medicine, Hamadan University of Medical Sciences, Hamadan, IR Iran
3 Department of Biostatistics and Epidemiology, School of Public Health, Hamadan University of Medical Sciences, Hamadan, IR Iran
4 Department of Health Services, Hamadan University of Medical Sciences, Hamedan, IR Iran
Article information
  • Jundishapur Journal of Microbiology: June 01, 2014, 7 (6); e10565
  • Published Online: June 1, 2014
  • Article Type: Research Article
  • Received: February 3, 2013
  • Revised: June 16, 2013
  • Accepted: June 25, 2013
  • DOI: 10.5812/jjm.10565

To Cite: Roshanaei G, Sabouri Ghannad M, Saatchi M, Khazaei S, Mirzaei M. Survival Rates of Human Immunodeficiency Virus and Tuberculosis Co-Infected Patients, Jundishapur J Microbiol. 2014 ; 7(6):e10565. doi: 10.5812/jjm.10565.

Copyright © 2014, Ahvaz Jundishapur University of Medical Sciences. This is an open-access article distributed under the terms of the Creative Commons Attribution-NonCommercial 4.0 International License (http://creativecommons.org/licenses/by-nc/4.0/) which permits copy and redistribute the material just in noncommercial usages, provided the original work is properly cited.
1. Background
2. Objectives
3. Patients and Methods
4. Results
5. Discussion
  • 1. Wilkinson KA, Schwander S, Torok ME, Meintjes G. Human immunodeficiency virus-associated tuberculosis. Clin Dev Immunol. 2011; 2011: 513967[DOI][PubMed]
  • 2. AIDS Control and Prevention (AIDSCAP) Project of Family Health Internal, The Francois-Xavier Bagnoud Center for Public Health and Human Rights of the Harvard School of Public Health UNAIDS 1996;
  • 3. Raghavan S, Alagarasu K, Selvaraj P. Immunogenetics of HIV and HIV associated tuberculosis. Tuberculosis (Edinb). 2012; 92(1): 18-30[DOI][PubMed]
  • 4. Raviglione MC, Snider DE, Jr., Kochi A. Global epidemiology of tuberculosis. Morbidity and mortality of a worldwide epidemic. JAMA. 1995; 273(3): 220-6[PubMed]
  • 5. Pawlowski A, Jansson M, Skold M, Rottenberg ME, Kallenius G. Tuberculosis and HIV co-infection. PLoS Pathog. 2012; 8(2)[DOI][PubMed]
  • 6. Manosuthi W, Chottanapand S, Thongyen S, Chaovavanich A, Sungkanuparph S. Survival rate and risk factors of mortality among HIV/tuberculosis-coinfected patients with and without antiretroviral therapy. J Acquir Immune Defic Syndr. 2006; 43(1): 42-6[DOI][PubMed]
  • 7. Hatami H. Textbook of Public Health. 2006; : 1126-7
  • 8. The status of TB/HIV Co-infection. 2011;
  • 9. Tv Website (jamejamonline) 2012;
  • 10. World Health Organization . Interim proposal for a WHO staging system for HIV infection and disease. Wkly Epidemiol Rec. 1990; 65(29): 221-4
  • 11. WHO . Tuberculosis facts 2008;
  • 12. Gabunia P, Salakaia A, Kiria N, Kandelaki G, Tsertsvadze T. TB/HIV co infection in Georgia. Georgian Med News. 2008; (165): 7-10[PubMed]
  • 13. Omair MA, Al-Ghamdi AA, Alrajhi AA. Incidence of tuberculosis in people living with the human immunodeficiency virus in Saudi Arabia. Int J Tuberc Lung Dis. 2010; 14(5): 600-3[PubMed]
  • 14. Jam S, Sabzvari D, SeyedAlinaghi S, Fattahi F, Jabbari H, Mohraz M. Frequency of Mycobacterium tuberculosis infection among Iranian patients with HIV/AIDS by PPD test. Acta Med Iran. 2010; 48(1): 67-71[PubMed]
  • 15. Ifebunandu NA, Ukwaja KN, Obi SN. Treatment outcome of HIV-associated tuberculosis in a resource-poor setting. Trop Doct. 2012; 42(2): 74-6[DOI][PubMed]
  • 16. Chernyaeva E, Dobrynin P, Pestova N, Matveeva N, Zhemkov V, Kozlov A. Molecular genetic analysis of Mycobacterium tuberculosis strains spread in different patient groups in St. Petersburg, Russia. Eur J Clin Microbiol Infect Dis. 2012; 31(8): 1753-7[DOI][PubMed]
  • 17. Ghannad MS, Arab SM, Mirzaei M, Moinipur A. Epidemiologic study of human immunodeficiency virus (HIV) Infection in the patients referred to health centers in Hamadan province, Iran. AIDS Res Hum Retroviruses. 2009; 25(3): 277-83[DOI][PubMed]
  • 18. Limmahakhun S, Chaiwarith R, Nuntachit N, Sirisanthana T, Supparatpinyo K. Treatment outcomes of patients co-infected with tuberculosis and HIV at Chiang Mai University Hospital, Thailand. Int J STD AIDS. 2012; 23(6): 414-8[DOI][PubMed]
  • 19. Sungkanuparph S, Eampokalap B, Chottanapund S, Bed ST, Manosuthi W. Declining prevalence of drug-resistant tuberculosis among HIV/tuberculosis co-infected patients receiving antiretroviral therapy. J Med Assoc Thai. 2007; 90(5): 884-8[PubMed]
  • 20. Orofino Rde L, Brasil PE, Trajman A, Schmaltz CA, Dalcolmo M, Rolla VC. Predictors of tuberculosis treatment outcomes. J Bras Pneumol. 2012; 38(1): 88-97[PubMed]
Creative Commons License Except where otherwise noted, this work is licensed under Creative Commons Attribution Non Commercial 4.0 International License .

Search Relations:



Create Citiation Alert
via Google Reader

Readers' Comments